Neovascularisation, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma

Doménico Ribatti(University of Bari Aldo Moro), Franco Dammacco(University of Bari Aldo Moro), Roberto Ria(University of Bari Aldo Moro), Beatrice Nico(University of Bari Aldo Moro), Andrea Marzullo(University of Bari Aldo Moro), Luisa Roncali(University of Bari Aldo Moro), Raffaele Filotico(University of Bari Aldo Moro), Angelo Vacca(University of Bari Aldo Moro)
European Journal of Cancer
March 1, 2003
10.1016/s0959-8049(02)00150-8
Cited by 139

Related Papers

Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic.
|PubMed|1997|279
Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients
|Blood|2011|268
Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved Survival
|Journal of Clinical Oncology|2014|210
Accuracy in melanoma detection: A 10-year multicenter survey
|Journal of the American Academy of Dermatology|2011|209
The E6 and E7 Proteins of the Cutaneous Human Papillomavirus Type 38 Display Transforming Properties
|Journal of Virology|2003|187